Related references
Note: Only part of the references are listed.α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy?
Aoife P. Kiely et al.
ACTA NEUROPATHOLOGICA (2013)
Neuropsychiatric Symptoms in Patients with Dementias Associated with Cortical Lewy Bodies: Pathophysiology, Clinical Features, and Pharmacological Management
Clive Ballard et al.
DRUGS & AGING (2013)
Monoclonal antibodies selective for α-synuclein oligomers/protofibrils recognize brain pathology in Lewy body disorders and α-synuclein transgenic mice with the disease-causing A30P mutation
Therese Fagerqvist et al.
JOURNAL OF NEUROCHEMISTRY (2013)
α-Synuclein Vaccination Prevents the Accumulation of Parkinson Disease-Like Pathologic Inclusions in Striatum in Association With Regulatory T Cell Recruitment in a Rat Model
Vanesa Sanchez-Guajardo et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2013)
Enteric alpha-synuclein expression is increased in Parkinson's disease but not Alzheimer's disease
Andrea Gold et al.
MOVEMENT DISORDERS (2013)
Naturally occurring α-synuclein autoantibody levels are lower in patients with Parkinson disease
Daniela Besong-Agbo et al.
NEUROLOGY (2013)
Developing Therapeutic Antibodies for Neurodegenerative Disease
Y. Joy Yu et al.
NEUROTHERAPEUTICS (2013)
Natalizumab Bench to Bedside and Beyond
Richard Rudick et al.
JAMA NEUROLOGY (2013)
Protein degradation pathways in Parkinson's disease: curse or blessing
Darius Ebrahimi-Fakhari et al.
ACTA NEUROPATHOLOGICA (2012)
Immunotherapy of Cancer: Reprogramming Tumor-Immune Crosstalk
Kyle K. Payne et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
Extracellular Alpha-Synuclein Oligomers Modulate Synaptic Transmission and Impair LTP Via NMDA-Receptor Activation
Maria Jose Diogenes et al.
JOURNAL OF NEUROSCIENCE (2012)
Endoplasmic Reticulum Stress Is Important for the Manifestations of α-Synucleinopathy In Vivo
Emanuela Colla et al.
JOURNAL OF NEUROSCIENCE (2012)
Antibody-Aided Clearance of Extracellular α-Synuclein Prevents Cell-to-Cell Aggregate Transmission
Eun-Jin Bae et al.
JOURNAL OF NEUROSCIENCE (2012)
Premotor signs and symptoms of multiple system atrophy
Milica Jecmenica-Lukic et al.
LANCET NEUROLOGY (2012)
Exosomal cell-to-cell transmission of alpha synuclein oligomers
Karin M. Danzer et al.
MOLECULAR NEURODEGENERATION (2012)
α-Synuclein and Anti-α-Synuclein Antibodies in Parkinson's Disease, Atypical Parkinson Syndromes, REM Sleep Behavior Disorder, and Healthy Controls
Lynnae M. Smith et al.
PLOS ONE (2012)
α-Synuclein in Parkinson disease and other neurodegenerative disorders
Michael Eller et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2011)
Phosphorylated α-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease
Penelope G. Foulds et al.
FASEB JOURNAL (2011)
α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells
Christian Hansen et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Immunoprotection against toxic biomarkers is retained during Parkinson's disease progression
Marina A. Gruden et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
β-Glucocerebrosidase gene mutations in two cohorts of Greek patients with sporadic Parkinson's disease
Marina Moraitou et al.
MOLECULAR GENETICS AND METABOLISM (2011)
Heavy-Chain Complementarity-Determining Regions Determine Conformation Selectivity of Anti-A beta Antibodies
Dag Sehlin et al.
NEURODEGENERATIVE DISEASES (2011)
Vaccination for Parkinson's disease
A. Schneeberger et al.
PARKINSONISM & RELATED DISORDERS (2011)
α-Synuclein Reactive Antibodies as Diagnostic Biomarkers in Blood Sera of Parkinson's Disease Patients
Kiran Yanamandra et al.
PLOS ONE (2011)
Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease
Eliezer Masliah et al.
PLOS ONE (2011)
Assessment of α-Synuclein Secretion in Mouse and Human Brain Parenchyma
Evangelia Emmanouilidou et al.
PLOS ONE (2011)
Antibodies against Alpha-Synuclein Reduce Oligomerization in Living Cells
Thomas Nasstrom et al.
PLOS ONE (2011)
Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson's disease
Kelly Del Tredici et al.
ACTA NEUROPATHOLOGICA (2010)
Safety and Changes in Plasma and Cerebrospinal Fluid Amyloid beta After a Single Administration of an Amyloid beta Monoclonal Antibody in Subjects With Alzheimer Disease
Eric R. Siemers et al.
CLINICAL NEUROPHARMACOLOGY (2010)
Alternative Activation of Macrophages: Mechanism and Functions
Siamon Gordon et al.
IMMUNITY (2010)
Direct Transfer of α-Synuclein from Neuron to Astroglia Causes Inflammatory Responses in Synucleinopathies
He-Jin Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Regulatory T Cells Attenuate Th17 Cell-Mediated Nigrostriatal Dopaminergic Neurodegeneration in a Model of Parkinson's Disease
Ashley D. Reynolds et al.
JOURNAL OF IMMUNOLOGY (2010)
Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson's disease
Oliver Riedel et al.
JOURNAL OF NEUROLOGY (2010)
Therapeutic antibodies in ophthalmology Old is new again
Charlotte Magdelaine-Beuzelin et al.
MABS (2010)
Detection of elevated levels of soluble -synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies
Katerina E. Paleologou et al.
BRAIN (2009)
Antibody Responses, Amyloid-β Peptide Remnants and Clinical Effects of AN-1792 Immunization in Patients with AD in an Interrupted Trial
Tyler A. Kokjohn et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2009)
Long-Term Follow-Up of Patients Immunized with AN1792: Reduced Functional Decline in Antibody Responders
Bruno Vellas et al.
CURRENT ALZHEIMER RESEARCH (2009)
Pre-fibrillar α-synuclein variants with impaired β-structure increase neurotoxicity in Parkinson's disease models
Damla Pinar Karpinar et al.
EMBO JOURNAL (2009)
Parkinson's disease: from monogenic forms to genetic susceptibility factors
Suzanne Lesage et al.
HUMAN MOLECULAR GENETICS (2009)
SUPPRESSION OF MAP KINASES INHIBITS MICROGLIAL ACTIVATION AND ATTENUATES NEURONAL CELL DEATH INDUCED BY α-SYNUCLEIN PROTOFIBRILS
H. Wilms et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2009)
Prions hijack tunnelling nanotubes for intercellular spread
Karine Gousset et al.
NATURE CELL BIOLOGY (2009)
An amyloid-β protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease
Anna Lord et al.
NEUROBIOLOGY OF DISEASE (2009)
Cognitive impairment in incident, untreated Parkinson disease The Norwegian ParkWest Study
D. Aarsland et al.
NEUROLOGY (2009)
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
S. Salloway et al.
NEUROLOGY (2009)
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein
Paula Desplats et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
An scFv intrabody against the nonamyloid component of α-synuclein reduces intracellular aggregation and toxicity
Sandra M. Lynch et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
Mariese A. Hely et al.
MOVEMENT DISORDERS (2008)
Synuclein activates microglia in a model of Parkinson's disease
Xiaomin Su et al.
NEUROBIOLOGY OF AGING (2008)
Formation of Toxic Oligomeric α-Synuclein Species in Living Cells
Tiago Fleming Outeiro et al.
PLOS ONE (2008)
Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson's disease
Ashley D. Reynolds et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Different species of α-synuclein oligomers induce calcium influx and seeding
Karin M. Danzer et al.
JOURNAL OF NEUROSCIENCE (2007)
Isolation of a human single chain antibody fragment against oligomeric α-synuclein that inhibits aggregation and prevents α-synuclein-induced toxicity
Sharareh Emadi et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Autoantibodies to alpha-synuclein in inherited Parkinson's disease
Katerina K. Papachroni et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Calpain-cleavage of α-synuclein -: Connecting proteolytic processing to disease-linked aggregation
Brian M. Dufty et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Presynaptic α-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies
Michael L. Kramer et al.
JOURNAL OF NEUROSCIENCE (2007)
CD4+ T cells from Copolymer-1 immunized mice protect dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease
Chad Laurie et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
Age-dependent cognitive decline and amygdala pathology in alpha-synuclein transgenic mice
Christian Freichel et al.
NEUROBIOLOGY OF AGING (2007)
Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease
Takahiko Tokuda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Detection of novel intracellular α-synuclein oligomeric species by fluorescence lifetime imaging
Jochen Klucken et al.
FASEB JOURNAL (2006)
Detection of oligomeric forms of α-synuclein protein in human plasma as a potential biomarker for Parkinson's disease
Omar M. A. El-Agnaf et al.
FASEB JOURNAL (2006)
Diagnosis and management of dementia with Lewy bodies - Third report of the DLB consortium
IG McKeith et al.
NEUROLOGY (2005)
Effects of α-synuclein immunization in a mouse model of Parkinson's disease
E Masliah et al.
NEURON (2005)
Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial
S Gilman et al.
NEUROLOGY (2005)
Aggregated α-synuclein activates microglia:: a process leading to disease progression in Parkinson's disease
W Zhang et al.
FASEB JOURNAL (2005)
Aggresomes formed by α-synuclein and synphilin-1 are cytoprotective
M Tanaka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Comparison of kindreds with parkinsonism and α-synuclein genomic multiplications
M Farrer et al.
ANNALS OF NEUROLOGY (2004)
α-synuclein locus duplication as a cause of familial Parkinson's disease
MC Chartier-Harlin et al.
LANCET (2004)
Causal relation between α-synuclein gene duplication and familial Parkinson's disease
P Ibáñez et al.
LANCET (2004)
A human single-chain Fv intrabody blocks aberrant cellular effects of overexpressed α-synuclein
C Zhou et al.
MOLECULAR THERAPY (2004)
Assessment of the Bioactivity of Antibodies against beta-Amyloid Peptide in vitro and in vivo
M. Hasan Mohajeri et al.
NEURODEGENERATIVE DISEASES (2004)
Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease
I Ferrer et al.
BRAIN PATHOLOGY (2004)
Role of microglia in central nervous system infections
RB Rock et al.
CLINICAL MICROBIOLOGY REVIEWS (2004)
The formation of highly soluble oligomers of α-synuclein is regulated by fatty acids and enhanced in Parkinson's disease
R Sharon et al.
NEURON (2003)
Passage of amyloid β protein antibody across the blood-brain barrier in a mouse model of Alzheimer's disease
WA Banks et al.
PEPTIDES (2002)
Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease
RB DeMattos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Evidence for a partially folded intermediate in α-synuclein fibril formation
VN Uversky et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
F Bard et al.
NATURE MEDICINE (2000)
Dopaminergic loss and inclusion body formation in α-synuclein mice:: Implications for neurodegenerative disorders
E Masliah et al.
SCIENCE (2000)
Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease:: Implications for pathogenesis and therapy
KA Conway et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
